Medpace Holdings, Inc.

符号: MEDP

NASDAQ

392.57

USD

今天的市场价格

38.7448
市盈率
0.0000
PEG比率
12.16B
MRK市值
0.00%
DIV收益率

Medpace Holdings, Inc. (MEDP) 财务报表

Q: 什么是 Medpace Holdings, Inc. (MEDP) 总资产是多少？

Medpace Holdings, Inc. (MEDP) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Medpace Holdings, Inc. (MEDP). 的默认数据。公司收入显示 846.938 M 的平均值，即 0.175 % 增长率。整个期间的平均毛利润为 265.274 M，即 0.121 %. 平均毛利率为 0.345 %. 公司去年的净收入增长率为 0.153 %，等于 0.628 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Medpace Holdings, Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.225. 在流动资产领域，MEDP 的报告货币为593.828. 这些资产中的很大一部分，即 245.449 是现金和短期投资。与去年的数据相比，该部分的变化率为7.684%. 公司的长期投资虽然不是其重点，但以报告货币计算的0（如果有的话）为0。这表明与上一报告期相比，0.000% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 142.122. 这一数字表明，-0.248% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 558.95. 这方面的年同比变化率为 0.447%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为298.4，存货估值为 0，商誉估值为 662.4（如有. 无形资产总额（如果有）按 35.81 估值.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014
balance-sheet.row.cash-and-short-term-investments	786.8	245.4	28.3	461.3	277.8	131.9	23.3	26.5	37.1	14.9	54.3
balance-sheet.row.short-term-investments	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	1145.4	298.4	253.4	186.4	161	155.7	133.4	83.1	79.8	65.1	65.2
balance-sheet.row.inventory	0	0	0	0	0	0	0	0	0.3	2.9	1.1
balance-sheet.row.other-current-assets	234.34	50	52.3	43.2	34.9	29.4	21.4	20.4	16.1	11.9	12.7
balance-sheet.row.total-current-assets	2166.54	593.8	334	690.9	473.7	317	178.1	130	133.2	94.7	133.3
balance-sheet.row.property-plant-equipment-net	1036.38	265.4	248.9	222.7	198.8	99.4	52.3	48.7	43.8	37.5	38.1
balance-sheet.row.goodwill	2649.58	662.4	662.4	662.4	662.4	662.4	661	661	661	661	670.3
balance-sheet.row.intangible-assets	144.52	35.8	38	41.4	46.5	54.4	69.2	98.7	136.1	186.7	249.9
balance-sheet.row.goodwill-and-intangible-assets	2794.11	698.2	700.4	703.8	708.9	716.7	730.2	759.7	797.1	847.7	920.2
balance-sheet.row.long-term-investments	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	260.77	74.4	48.1	25.1	0.5	0.4	0.7	6.3	0.1	0.2	0.1
balance-sheet.row.other-non-current-assets	88.47	25	21.1	17.4	8.8	9.5	6.7	5.9	4.9	3.9	5.2
balance-sheet.row.total-non-current-assets	4179.74	1063	1018.5	969	917	826	789.8	820.7	845.9	889.3	963.6
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	6346.28	1656.8	1352.5	1659.9	1390.7	1143.1	967.9	950.7	979.1	984	1096.9
balance-sheet.row.account-payables	118.9	31.9	33.1	25.7	26.6	22.4	16.7	16.7	10.9	8.7	6.3
balance-sheet.row.short-term-debt	885.06	293	50	159.3	134.4	109.3	87.5	16.5	12.4	20.1	20.3
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	560.71	142.1	138.9	131	115.1	45.2	79.7	205.1	151.3	377.9	491.5
Deferred Revenue Non Current	0	0	0	0	0	0	84.5	11.5	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	6.99	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	392.9	40.4	257.7	27.6	23.5	19	4.9	85.8	79.6	54.1	48.9
balance-sheet.row.total-non-current-liabilities	671.08	172.7	162.6	149.8	144.8	73.8	121.2	254.5	199.8	436.6	561.3
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	560.71	142.1	138.9	131	115.1	45.2	0	0	0	0	0
balance-sheet.row.total-liab	4253.81	1097.9	966.1	707	584.9	416.8	378.2	447.2	368.4	570.6	694.9
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1.23	0.3	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.3	0.3
balance-sheet.row.retained-earnings	-1012	-221.6	-359.8	235	115.2	68.1	-41.5	-120.4	-9.6	-23	-14.3
balance-sheet.row.accumulated-other-comprehensive-income-loss	-46.18	-10.1	-12.4	-4.8	-0.1	-2.7	-2.5	-0.7	-3.7	-2.6	-1.6
balance-sheet.row.other-total-stockholders-equity	3149.41	790.4	758.3	722.4	690.3	660.6	633.4	624.3	623.6	438.7	417.6
balance-sheet.row.total-stockholders-equity	2092.46	559	386.4	952.9	805.8	726.3	589.7	503.5	610.7	413.5	402
balance-sheet.row.total-liabilities-and-stockholders-equity	6346.28	1656.8	1352.5	1659.9	1390.7	1143.1	967.9	950.7	979.1	984	1096.9
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	2092.46	559	386.4	952.9	805.8	726.3	589.7	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	6346.28	-	-	-	-	-	-	-	-	-	-
Total Investments	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-debt	615.71	142.1	188.9	131	115.1	45.2	79.7	221.6	163.6	377.9	491.5
balance-sheet.row.net-debt	-171.1	-103.3	160.6	-330.3	-162.6	-86.7	56.4	195.1	126.5	363	437.2

现金流量表

在 Medpace Holdings, Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 0.130 的转变。该公司最近通过发行 11.38 扩大了股本，与上一年相比出现了-0.324 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-34629000.000. 与上一年相比， -0.106 发生了变化. 在同一时期，公司记录了 26.33, 2.02 和 -155，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-11.38 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 116.38，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2013
cash-flows.row.net-income	312.51	282.8	245.4	181.8	145.4	100.4	73.2	39.1	13.4	-8.7	24.8
cash-flows.row.depreciation-and-amortization	27.36	26.3	22.3	21.1	19.5	23.2	38.8	46.5	58.1	69.5	30.5
cash-flows.row.deferred-income-tax	-24.92	-25.1	-23	-37.1	0.5	10.1	3.9	3.2	-9	-12.7	6
cash-flows.row.stock-based-compensation	19.39	20.5	21.4	14.5	13.8	20.7	6.5	4.5	9.8	22.3	2
cash-flows.row.change-in-working-capital	151.12	106.5	106.1	66.7	66.3	35.6	39.6	12.9	7.1	1.9	28.9
cash-flows.row.account-receivables	-24.82	-48.3	-66.9	-25	-5.5	-21.3	-27	-2.9	-13.7	0	0
cash-flows.row.inventory	43.94	66.2	0	25	5.5	21.3	27.8	0.4	6.3	0	0
cash-flows.row.account-payables	-10.76	1.1	6.4	1.9	-2.6	4.7	1.3	4.8	0.7	2.5	0.6
cash-flows.row.other-working-capital	179.05	87.5	166.5	64.8	68.9	30.9	37.5	10.5	13.9	-0.6	28.3
cash-flows.row.other-non-cash-items	20.52	22.4	15.9	16.3	13.2	11.9	-5.4	-8.8	12.3	11.8	5.9
cash-flows.row.net-cash-provided-by-operating-activities	505.98	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-32.63	-36.6	-36.9	-28.3	-31.3	-17.9	-16	-12.3	-13.5	-6.5	-4.6
cash-flows.row.acquisitions-net	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	10.04	2	-1.9	-3.1	0.1	-1.2	-0.9	0.1	0.1	0	0.1
cash-flows.row.net-cash-used-for-investing-activites	-22.6	-34.6	-38.7	-31.4	-31.2	-19.1	-17	-12.2	-13.4	-6.4	-4.5
cash-flows.row.debt-repayment	-130	-155	-274.2	0	0	-80.4	-142.2	-42.4	-390.6	-116.1	-96.4
cash-flows.row.common-stock-issued	16.57	11.4	22.1	17.6	16	6.5	0	0	173.6	0.6	1.2
cash-flows.row.common-stock-repurchased	-23.87	-144	-847.8	-62.1	-98.3	0	0	-155.6	0	0	0
cash-flows.row.dividends-paid	0	-11.4	-22.1	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	-23.43	116.4	346.3	-44.5	-82.3	-73.9	0.6	100.1	159	-1	-0.6
cash-flows.row.net-cash-used-provided-by-financing-activities	-122.3	-182.6	-775.8	-44.5	-82.3	-73.9	-141.6	-97.8	-58	-116.5	-95.9
cash-flows.row.effect-of-forex-changes-on-cash	-0.99	1.1	-6.6	-4	0.7	-0.2	-1.2	1.8	-0.6	-0.6	0.2
cash-flows.row.net-change-in-cash	360.09	217.2	-433	183.5	145.8	108.6	-3.2	-10.9	19.7	-39.4	-2
cash-flows.row.cash-at-end-of-period	786.8	245.4	28.3	461.3	277.8	131.9	23.3	26.5	37.4	14.9	23.9
cash-flows.row.cash-at-beginning-of-period	426.72	28.3	461.3	277.8	131.9	23.3	26.5	37.4	17.7	54.3	25.9
cash-flows.row.operating-cash-flow	505.98	433.4	388.1	263.3	258.7	201.9	156.6	97.4	91.7	84.1	98.1
cash-flows.row.capital-expenditure	-32.63	-36.6	-36.9	-28.3	-31.3	-17.9	-16	-12.3	-13.5	-6.5	-4.6
cash-flows.row.free-cash-flow	473.34	396.7	351.2	235.1	227.3	184	140.6	85.1	78.2	77.7	93.6

利润表行

Medpace Holdings, Inc. 的收入与上期相比变化了 0.292%。据报告, MEDP 的毛利润为 524.5。该公司的营业费用为 187.68，与上年相比变化了 22.075%. 折旧和摊销费用为 26.33，与上一会计期间相比变化了 0.178%. 营业费用报告为 187.68，显示22.075% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长0.209%. 营业收入为 336.82，与上年相比变化了0.209%. 净利润的变化率为 0.153%。去年的净收入为282.81.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2013
income-statement-row.row.total-revenue	1962.81	1885.8	1460	1142.4	925.9	861	704.6	436.2	421.6	359.1	272.9
income-statement-row.row.cost-of-revenue	1413.35	1361.3	1027.6	814.2	647.2	615.3	489.1	261.5	249.5	202.7	148.4
income-statement-row.row.gross-profit	549.46	524.5	432.4	328.2	278.7	245.7	215.5	174.7	172.1	156.4	124.5
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	0	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	41.01	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	1.5	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	12.98	1.3	22.3	21.1	19.5	23.2	1.1	-0.4	-0.4	0.2	2.4
income-statement-row.row.operating-expenses	194.77	187.7	153.7	129.5	111.7	118.4	114.5	109.8	119.6	126.5	65.6
income-statement-row.row.cost-and-expenses	1608.12	1549	1181.3	943.8	758.9	733.7	603.5	371.3	369.1	329.2	214
income-statement-row.row.interest-income	3.31	0	2.9	0.1	0.3	1.6	0	0	0	0	0
income-statement-row.row.interest-expense	7.43	-0.5	2.9	-0.1	0.3	1.6	8.2	7.6	19.4	27.3	18
income-statement-row.row.selling-and-marketing-expenses	1.5	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	1.89	-0.7	4.2	3.2	1.5	-2.4	1.1	-0.4	-11.1	-10.4	-1.7
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	12.98	1.3	22.3	21.1	19.5	23.2	1.1	-0.4	-0.4	0.2	2.4
income-statement-row.row.total-operating-expenses	1.89	-0.7	4.2	3.2	1.5	-2.4	1.1	-0.4	-11.1	-10.4	-1.7
income-statement-row.row.interest-expense	7.43	-0.5	2.9	-0.1	0.3	1.6	8.2	7.6	19.4	27.3	18
income-statement-row.row.depreciation-and-amortization	26.08	26.3	22.3	21.1	19.5	23.2	38.8	46.5	58.1	69.5	30.5
income-statement-row.row.ebitda-caps	381.37	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	354.69	336.8	278.7	198.6	167	127.3	101	64.9	52.5	20.6	58.9
income-statement-row.row.income-before-tax	362.43	335.7	282.9	201.9	168.5	124.8	94	56.9	22	-7.8	39.1
income-statement-row.row.income-tax-expense	49.93	52.9	37.5	20	23.1	24.4	20.8	17.8	8.5	0.8	14.3
income-statement-row.row.net-income	312.51	282.8	245.4	181.8	145.4	100.4	73.2	39.1	13.4	-8.7	24.8